2. Signaling Pathways
  3. Immunology/Inflammation
  4. Nectin-4
  5. Nectin-4 Inhibitor

Nectin-4 Inhibitor

Nectin-4 Inhibitors (3):

Cat. No. Product Name Effect Purity
  • HY-P99016
    Enfortumab
    		Inhibitor 99.90%
    Enfortumab is a humanized derived anti-Nectin-4 antibody that can be conjugated with the highly efficient microtubule disruptor MMAE (HY-15162) to generate the antibody drug conjugate (ADC) Enfortumab vedotin (HY-P99016A). Enfortumab can be used for the study of locally advanced and metastatic urothelial carcinoma.
  • HY-P99016B
    Enfortumab vedotin-ejfv (solution)
    		Inhibitor 99.78%
    Enfortumab vedotin-ejfv (solution) is an anti-Nectin-4 antibody-drug conjugate for the management of urothelial carcinoma.
  • HY-P99016A
    Enfortumab vedotin-ejfv
    		Inhibitor 99.28%
    Enfortumab vedotin-ejfv is an anti-Nectin-4 antibody-drug conjugate for the management of urothelial carcinoma.